Achelios Therapeutics
NC - DurhamBiotechnology
Focus: Achelios Therapeutics is a pre-revenue biotech company focused on developing topical small molecule therapeutics for neurology, specifically migraine headaches. Founded in 2022 and based in Durham, NC, the company is in early-stage development with minimal clinical data.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
0
About Achelios Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Achelios Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ELS-M11
Migraine HeadachesClinical Trials (1)
NCT02057315Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine
Phase 1/2Help build intelligence for Achelios Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.